A Phase 3 Study of AGA111 in Patients With Degenerative Disc Disease Undergoing Lumbar Interbody Fusion

Clinical trial NCT06115512 · TERMINATED

Trial details

NCT number: NCT06115512
Sponsor: Angitia Biopharmaceuticals
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Degenerative Disc Disease

Start date: 2023-12-08
Primary completion: 2025-11-28
Enrollment: 412

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.